These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1783 related items for PubMed ID: 37346073

  • 21. Overweight/obesity-related transcriptomic signature as a correlate of clinical outcome, immune microenvironment, and treatment response in hepatocellular carcinoma.
    Feng NN, Du XY, Zhang YS, Jiao ZK, Wu XH, Yang BM.
    Front Endocrinol (Lausanne); 2022; 13():1061091. PubMed ID: 36714595
    [Abstract] [Full Text] [Related]

  • 22. Comprehensive analysis of immune-related gene signature based on ssGSEA algorithms in the prognosis and immune landscape of hepatocellular carcinoma.
    Wang L, Wang L, He P.
    Front Genet; 2022; 13():1064432. PubMed ID: 36568383
    [Abstract] [Full Text] [Related]

  • 23. Identification of metabolism-related long non-coding RNA (lncRNA) signature predicts prognosis and immune infiltrates in hepatocellular carcinoma.
    Wang X, Qian J, Yao N, Pocha C, Kang KJ, Angelico R, Zhu G.
    Ann Transl Med; 2022 May; 10(10):595. PubMed ID: 35722420
    [Abstract] [Full Text] [Related]

  • 24. A novel five-gene signature predicts overall survival of patients with hepatocellular carcinoma.
    Wang Z, Pan L, Guo D, Luo X, Tang J, Yang W, Zhang Y, Luo A, Gu Y, Pan Y.
    Cancer Med; 2021 Jun; 10(11):3808-3821. PubMed ID: 33934539
    [Abstract] [Full Text] [Related]

  • 25. Identification of hepatocellular carcinoma-related subtypes and development of a prognostic model: a study based on ferritinophagy-related genes.
    Wang G, Li J, Zhu L, Zhou Z, Ma Z, Zhang H, Yang Y, Niu Q, Wang X.
    Discov Oncol; 2023 Aug 09; 14(1):147. PubMed ID: 37555866
    [Abstract] [Full Text] [Related]

  • 26. Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma.
    Xu Q, Xu H, Chen S, Huang W.
    Front Cell Dev Biol; 2021 Aug 09; 9():710207. PubMed ID: 34409040
    [Abstract] [Full Text] [Related]

  • 27. Integration of single-cell RNA-seq and bulk RNA-seq to construct liver hepatocellular carcinoma stem cell signatures to explore their impact on patient prognosis and treatment.
    Liu L, Zhang M, Cui N, Liu W, Di G, Wang Y, Xi X, Li H, Shen Z, Gu M, Wang Z, Jiang S, Liu B.
    PLoS One; 2024 Aug 09; 19(4):e0298004. PubMed ID: 38635528
    [Abstract] [Full Text] [Related]

  • 28. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
    Li H, Lin D, Yu Z, Li H, Zhao S, Hainisayimu T, Liu L, Wang K.
    Front Immunol; 2022 Aug 09; 13():947802. PubMed ID: 36405735
    [Abstract] [Full Text] [Related]

  • 29. System analysis based on the cuproptosis-related genes identifies LIPT1 as a novel therapy target for liver hepatocellular carcinoma.
    Yan C, Niu Y, Ma L, Tian L, Ma J.
    J Transl Med; 2022 Oct 04; 20(1):452. PubMed ID: 36195876
    [Abstract] [Full Text] [Related]

  • 30. Characterizing the key genes of COVID-19 that regulate tumor immune microenvironment and prognosis in hepatocellular carcinoma.
    Gao S, Zhang L, Wang H.
    Funct Integr Genomics; 2023 Aug 04; 23(3):262. PubMed ID: 37540264
    [Abstract] [Full Text] [Related]

  • 31. Comprehensive analysis to identify the neurotransmitter receptor-related genes as prognostic and therapeutic biomarkers in hepatocellular carcinoma.
    Wang X, Li Y, Shi Y, Luo J, Zhang Y, Pan Z, Wu F, Tian J, Yu W.
    Front Cell Dev Biol; 2022 Aug 04; 10():887076. PubMed ID: 35990607
    [Abstract] [Full Text] [Related]

  • 32. The fatty acid-related gene signature stratifies poor prognosis patients and characterizes TIME in cutaneous melanoma.
    Hua S, Wang W, Yao Z, Gu J, Zhang H, Zhu J, Xie Z, Jiang H.
    J Cancer Res Clin Oncol; 2024 Jan 27; 150(2):40. PubMed ID: 38279987
    [Abstract] [Full Text] [Related]

  • 33. A signature based on neutrophil extracellular trap-related genes for the assessment of prognosis, immunoinfiltration, mutation and therapeutic response in hepatocellular carcinoma.
    Wang L, Wang Q, Li Y, Qi X, Fan X.
    J Gene Med; 2024 Jan 27; 26(1):e3588. PubMed ID: 37715643
    [Abstract] [Full Text] [Related]

  • 34. Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis.
    Zhu M, Zeng Q, Fan T, Lei Y, Wang F, Zheng S, Wang X, Zeng H, Tan F, Sun N, Xue Q, He J.
    Front Immunol; 2022 Jan 27; 13():783495. PubMed ID: 35222371
    [Abstract] [Full Text] [Related]

  • 35. Construction of a Cancer Stem Cell related Histone Acetylation Regulatory Genes Prognostic Model for Hepatocellular Carcinoma via Bioinformatics Analysis: Implications for Tumor Chemotherapy and Immunity.
    Dai Q, Zhu J, Yang J, Zhang CY, Yang WJ, Pan BS, Yang XR, Guo W, Wang BL.
    Curr Stem Cell Res Ther; 2024 Mar 28. PubMed ID: 38561604
    [Abstract] [Full Text] [Related]

  • 36. Comprehensive FGFR3 alteration-related transcriptomic characterization is involved in immune infiltration and correlated with prognosis and immunotherapy response of bladder cancer.
    Xu T, Xu W, Zheng Y, Li X, Cai H, Xu Z, Zou Q, Yu B.
    Front Immunol; 2022 Mar 28; 13():931906. PubMed ID: 35958598
    [Abstract] [Full Text] [Related]

  • 37. Comprehensive analysis and immune landscape of chemokines- and chemokine receptors-based signature in hepatocellular carcinoma.
    Zhang Z, Mao M, Wang F, Zhang Y, Shi J, Chang L, Wu X, Zhang Z, Xu P, Lu S.
    Front Immunol; 2023 Mar 28; 14():1164669. PubMed ID: 37545521
    [Abstract] [Full Text] [Related]

  • 38. A novel copper-induced cell death-related lncRNA prognostic signature associated with immune infiltration and clinical value in gastric cancer.
    Wang L, Xiao K, Dong Z, Meng T, Cheng X, Xu Y.
    J Cancer Res Clin Oncol; 2023 Sep 28; 149(12):10543-10559. PubMed ID: 37291405
    [Abstract] [Full Text] [Related]

  • 39. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.
    Liu C, Liu D, Wang F, Xie J, Liu Y, Wang H, Rong J, Xie J, Wang J, Zeng R, Zhou F, Xie Y.
    Front Med (Lausanne); 2022 Sep 28; 9():925661. PubMed ID: 35872794
    [Abstract] [Full Text] [Related]

  • 40. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
    Deng ZL, Zhou DZ, Cao SJ, Li Q, Zhang JF, Xie H.
    Inflammation; 2022 Aug 28; 45(4):1732-1751. PubMed ID: 35322324
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 90.